Trial intelligence / Profile preview

Concurrent vs Sequential Tamoxifen with Radiotherapy in Breast Cancer

NCT00896155Phase 3Unknown

Sponsor
Tata Memorial Hospital
Start
Dec 2008
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tamoxifen in breast cancer, sponsored by Tata Memorial Hospital. Status: unknown.

02

Drugs

tamoxifen
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00896155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00896155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call